Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease.
J Pers Med
; 11(11)2021 Nov 02.
Article
in En
| MEDLINE
| ID: mdl-34834482
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
/
Prognostic_studies
Language:
En
Journal:
J Pers Med
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: